• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过医院警报系统促进乙肝表面抗原和丙肝抗体阳性患者的通报与转诊。

Promoting notification and linkage of HBs antigen and anti-HCV antibody-positive patients through hospital alert system.

作者信息

Yoshioka Naoki, Okumura Akihiko, Yamamoto Yukie, Yamaguchi Katsura, Kaga Atsuro, Yamada Kentaro, Hirosaki Takuya, Ishikawa Daisuke, Kunii Shin, Watanabe Kazumasa, Utsunomiya Setsuo, Hayashi Kazuhiko, Ishigami Masatoshi, Goto Hidemi, Hirooka Yoshiki

机构信息

Department of Gastroenterology, The Aichi Prefectural Federation of Agricultural Cooperatives for Health and Welfare Kainan Hospital, 396 Minamihonden, Maegasu-cho, Yatomi, Aichi, 498-8502, Japan.

Department of Medical Technology, The Aichi Prefectural Federation of Agricultural Cooperatives for Health and Welfare Kainan Hospital, 396 Minamihonden, Maegasu-cho, Yatomi, Aichi, 498-8502, Japan.

出版信息

BMC Infect Dis. 2017 May 8;17(1):330. doi: 10.1186/s12879-017-2438-1.

DOI:10.1186/s12879-017-2438-1
PMID:28482818
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5422930/
Abstract

BACKGROUND

In Japan, approximately 0.9% and 1% of the whole population are infected with HBV and HCV, respectively. Doctors from departments other than gastroenterology often order viral hepatitis tests before an invasive examination or an operation. However, the notification of positive results to the patients and linkage to care is not appropriately performed. The in-hospital alert system was constructed to promote the notification and referral to gastroenterologists for patients with positive viral hepatitis tests, and its efficacy was evaluated.

METHODS

The patients who tested HBsAg and anti-HCV antibody by chemiluminescent enzyme immunoassays and chemiluminescent immunoassays were investigated for whether they were notified of the positive results and if they were referred to gastroenterologists at our hospital. The notification and referral rate was compared before (from January to December 2014) and after the introduction of the alert system (from February to September 2016).

RESULTS

HBsAg-positive rate was 1.1% (69/6543) before the introduction of the alert system and 0.8% (41/5403) after it. The notification rate has significantly improved from 46% to 73% (p = 0.0061) and the referral rate has improved from 16% to 27%, while not significant. Positive rate of anti-HCV antibody was 2.1% (139/6481) before the introduction of the alert system and 2.4% (128/5322) after it. The rate of notification and referral has significantly improved from 35% to 62% (p < 0.0001) and from 6% to 23% (p < 0.0001), respectively.

CONCLUSIONS

The in-hospital alert system increased the rates of notification and referral of the patients with positive viral hepatitis tests. Enlightenment of doctors other than gastroenterologists on viral hepatitis and cooperation of medical staffs would be helpful to improve the notification and referral rates.

摘要

背景

在日本,分别约有0.9%和1%的总人口感染乙肝病毒(HBV)和丙肝病毒(HCV)。胃肠病学以外科室的医生常在侵入性检查或手术前开具病毒性肝炎检测医嘱。然而,检测结果呈阳性时向患者的告知以及与治疗的衔接并未得到妥善执行。构建了院内警报系统以促进对病毒性肝炎检测结果呈阳性的患者进行告知并转诊至胃肠病科医生处,并对其效果进行了评估。

方法

对采用化学发光酶免疫分析法和化学发光免疫分析法检测乙肝表面抗原(HBsAg)和丙肝抗体的患者,调查其是否被告知检测结果呈阳性以及是否被转诊至我院的胃肠病科医生处。比较了警报系统引入前(2014年1月至12月)和引入后(2016年2月至9月)的告知率和转诊率。

结果

警报系统引入前HBsAg阳性率为1.1%(69/6543),引入后为0.8%(41/5403)。告知率从46%显著提高到73%(p = 0.0061),转诊率从16%提高到27%,但无统计学意义。警报系统引入前丙肝抗体阳性率为2.1%(139/6481),引入后为2.4%(128/5322)。告知率和转诊率分别从35%显著提高到62%(p < 0.0001)和从6%提高到23%(p < 0.0001)。

结论

院内警报系统提高了病毒性肝炎检测结果呈阳性患者的告知率和转诊率。对胃肠病学以外科室医生进行病毒性肝炎知识培训以及医护人员之间的合作,将有助于提高告知率和转诊率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b10/5422930/50d291c6ae47/12879_2017_2438_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b10/5422930/deef87fe403b/12879_2017_2438_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b10/5422930/50d291c6ae47/12879_2017_2438_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b10/5422930/deef87fe403b/12879_2017_2438_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b10/5422930/50d291c6ae47/12879_2017_2438_Fig2_HTML.jpg

相似文献

1
Promoting notification and linkage of HBs antigen and anti-HCV antibody-positive patients through hospital alert system.通过医院警报系统促进乙肝表面抗原和丙肝抗体阳性患者的通报与转诊。
BMC Infect Dis. 2017 May 8;17(1):330. doi: 10.1186/s12879-017-2438-1.
2
Putting "sticky notes" on the electronic medical record to promote intra-hospital referral of hepatitis B and C virus-positive patients to hepatology specialists: an exploratory study.在电子病历上贴“便利贴”以促进医院内丙型和乙型肝炎病毒阳性患者转诊至肝病专科医生:一项探索性研究。
BMC Infect Dis. 2016 Aug 12;16:410. doi: 10.1186/s12879-016-1765-y.
3
Hepatitis B and C status among health care workers in the five main hospitals in eastern Libya.利比亚东部五家主要医院医护人员的乙肝和丙肝感染状况
J Infect Public Health. 2014 Nov-Dec;7(6):534-41. doi: 10.1016/j.jiph.2014.07.006. Epub 2014 Aug 20.
4
Development of a Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect Hepatitis B Surface Antigen (HBsAg), Antibody to HBsAg, and Antibody to Hepatitis C.快速自动化荧光侧向流动免疫分析检测乙型肝炎表面抗原(HBsAg)、乙型肝炎表面抗体(抗 HBsAg)和丙型肝炎抗体的研制。
Ann Lab Med. 2018 Nov;38(6):578-584. doi: 10.3343/alm.2018.38.6.578.
5
The Rate of Referral of Hepatitis Virus Carriers to Hepatologists and the Factors Contributing to Referral.肝炎病毒携带者转诊至肝病专家的比例及转诊的影响因素。
Intern Med. 2017;56(15):1943-1948. doi: 10.2169/internalmedicine.56.8249. Epub 2017 Aug 1.
6
HBV and HCV infection in Japanese dental care workers.日本牙科护理人员中的乙肝病毒和丙肝病毒感染
Int J Mol Med. 2008 Jun;21(6):791-9.
7
Hepatitis B and hepatitis C prevalence and treatment referral among Asian Americans undergoing community-based hepatitis screening.亚裔美国人社区为基础的肝炎筛查中乙型肝炎和丙型肝炎的流行率及治疗转介。
Am J Public Health. 2010 Apr 1;100 Suppl 1(Suppl 1):S118-24. doi: 10.2105/AJPH.2009.162776. Epub 2010 Feb 10.
8
[Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].[对血液透析患者隐匿性乙型肝炎感染情况的调查]
Mikrobiyol Bul. 2007 Apr;41(2):227-33.
9
Dual positivity of hepatitis B surface antigen and anti-hepatitis C virus antibody and associated factors among apparently healthy patients of Ekiti State, Nigeria.尼日利亚埃基提州表面抗原乙型肝炎和抗丙型肝炎病毒抗体双阳性的明显健康患者及其相关因素。
Viral Immunol. 2012 Dec;25(6):448-55. doi: 10.1089/vim.2012.0042. Epub 2012 Nov 21.
10
[Markers of hepatitis B, C and HIV among orthopedic patients and staff at a Polish university hospital].[波兰大学医院骨科患者及医护人员中的乙肝、丙肝和艾滋病毒标志物]
Chir Narzadow Ruchu Ortop Pol. 2008 Mar-Apr;73(2):83-8.

引用本文的文献

1
Hepatitis C micro-elimination through the retrieval strategy of patients lost to follow-up.通过对失访患者的检索策略实现丙型肝炎的消灭目标。
BMC Gastroenterol. 2023 Feb 13;23(1):40. doi: 10.1186/s12876-023-02665-y.
2
The Korean Hepatitis C Virus Care Cascade in a Tertiary Institution: Current Status and Changes in Testing, Link to Care, and Treatment.韩国某三级医疗机构丙型肝炎病毒关怀链:检测、与治疗关联的现状和变化。
Gut Liver. 2022 Nov 15;16(6):964-975. doi: 10.5009/gnl210416. Epub 2022 Mar 31.
3
Micro-Elimination of Hepatitis C among Patients with Kidney Disease by Using Electronic Reminder System-A Hospital-Based Experience.

本文引用的文献

1
Putting "sticky notes" on the electronic medical record to promote intra-hospital referral of hepatitis B and C virus-positive patients to hepatology specialists: an exploratory study.在电子病历上贴“便利贴”以促进医院内丙型和乙型肝炎病毒阳性患者转诊至肝病专科医生:一项探索性研究。
BMC Infect Dis. 2016 Aug 12;16:410. doi: 10.1186/s12879-016-1765-y.
2
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013.1990年至2013年病毒性肝炎的全球负担:全球疾病负担研究2013的结果。
Lancet. 2016 Sep 10;388(10049):1081-1088. doi: 10.1016/S0140-6736(16)30579-7. Epub 2016 Jul 7.
3
利用电子提醒系统在肾病患者中实现丙型肝炎的微观消除——一项基于医院的经验
J Clin Med. 2022 Jan 14;11(2):423. doi: 10.3390/jcm11020423.
4
Management of Hepatitis B Surface Antigen and Hepatitis C Antibody-Positive Patients by Departments Not Specializing in Hepatology at a Suburban University Hospital in Japan: A Single-Center Observational Study.日本一所郊区大学医院非肝病专科部门对乙肝表面抗原和丙肝抗体阳性患者的管理:一项单中心观察性研究
Int J Gen Med. 2020 Oct 1;13:743-750. doi: 10.2147/IJGM.S268857. eCollection 2020.
5
Exploring the knowledge, attitudes and practices (KAP) of health care professionals on viral hepatitis notification in Gauteng, South Africa, 2015.2015年在南非豪登省对医护人员关于病毒性肝炎报告的知识、态度和行为进行调查。
Arch Public Health. 2018 Dec 6;76:75. doi: 10.1186/s13690-018-0319-8. eCollection 2018.
Early Identification and Linkage to Care for People with Chronic HBV and HCV Infection: The HepTLC Initiative.
慢性乙肝和丙肝感染者的早期识别与护理衔接:肝炎治疗与联系协作计划(HepTLC计划)
Public Health Rep. 2016 May-Jun;131 Suppl 2(Suppl 2):5-11. doi: 10.1177/00333549161310S202.
4
AASLD guidelines for treatment of chronic hepatitis B.美国肝病研究学会慢性乙型肝炎治疗指南。
Hepatology. 2016 Jan;63(1):261-83. doi: 10.1002/hep.28156. Epub 2015 Nov 13.
5
Randomized comparison of daclatasvir + asunaprevir versus telaprevir + peginterferon/ribavirin in Japanese hepatitis C virus patients.在日本丙型肝炎病毒患者中,达卡他韦+阿舒瑞韦与特拉匹韦+聚乙二醇干扰素/利巴韦林的随机对照比较
J Gastroenterol Hepatol. 2016 Jan;31(1):14-22. doi: 10.1111/jgh.13073.
6
Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.丙型肝炎指南:美国肝病研究学会-美国感染病学会关于丙型肝炎病毒感染成人检测、管理及治疗的建议
Hepatology. 2015 Sep;62(3):932-54. doi: 10.1002/hep.27950. Epub 2015 Aug 4.
7
Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial.在未经治疗和先前经治的日本基因 1 型丙型肝炎患者中,使用利巴韦林联合或不联合利巴韦林的雷迪帕韦和索非布韦固定剂量复方制剂治疗 12 周:一项开放标签、随机、3 期临床试验。
Lancet Infect Dis. 2015 Jun;15(6):645-53. doi: 10.1016/S1473-3099(15)70099-X. Epub 2015 Apr 8.
8
Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial.索磷布韦联合利巴韦林治疗日本慢性基因2型丙型肝炎病毒感染患者:一项开放标签的3期试验。
J Viral Hepat. 2014 Nov;21(11):762-8. doi: 10.1111/jvh.12312. Epub 2014 Sep 8.
9
Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection.长期恩替卡韦治疗可降低乙型肝炎病毒感染患者肝细胞癌的发生率。
Hepatology. 2013 Jul;58(1):98-107. doi: 10.1002/hep.26180. Epub 2013 Mar 6.
10
Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.全球丙型肝炎病毒感染的流行病学:特定年龄组丙型肝炎病毒抗体血清流行率的新估计。
Hepatology. 2013 Apr;57(4):1333-42. doi: 10.1002/hep.26141. Epub 2013 Feb 4.